COMMUNIQUÉS West-GlobeNewswire

-
Arbutus Names New Members to its Board of Directors
22/10/2018 -
Nuvectra® to Report Third Quarter 2018 Financial Results on October 29, 2018
22/10/2018 -
Sharp Rees-Stealy Medical Group leverages Allscripts EHR to achieve HIMSS Analytics O-EMRAM Stage 7
22/10/2018 -
Dentsply Sirona to Host Third Quarter 2018 Conference Call on November 8th
22/10/2018 -
Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at AMCP Nexus 2018
22/10/2018 -
Results from Celtaxsys’ Acebilustat Phase 2 Trial in Cystic Fibrosis Patients Showing Clinically Meaningful Improvement in Pulmonary Exacerbations Presented at the North American Cystic Fibrosis Conference
22/10/2018 -
Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346
22/10/2018 -
Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150
22/10/2018 -
Opiant Pharmaceuticals to Participate in Opioid Panel at the BARDA Industry Day
22/10/2018 -
Nova Leap Health Corp. Completes Purchase of New Hampshire Home Health Care Business
22/10/2018 -
OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer
22/10/2018 -
Coherus BioSciences to Report Third Quarter 2018 Financial Results on November 8th
22/10/2018 -
Aeglea BioTherapeutics Announces Positive Interim Clinical Data for Pegzilarginase in Advanced Melanoma Patients at the European Society for Medical Oncology 2018 Congress
22/10/2018 -
Ovid Therapeutics to Host Conference Call and Webcast on Thursday, October 25, at 10:30 a.m. EDT
22/10/2018 -
PetMed Express D/B/A 1-800-PetMeds Announces its Second Quarter Financial Results
22/10/2018 -
Nemaura to Host Investor Webinar on October 23rd 2018 to Provide Update on Recent Developments
22/10/2018 -
Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer
22/10/2018 -
Extendicare Announces Timing of 2018 Third Quarter Results and Conference Call
22/10/2018 -
Quotient Limited to Report Fiscal Second Quarter 2019 Financial Results and Host Conference Call
22/10/2018
Pages